Since its formation in 2002, ZeaChem has continued to progress its biorefining technology advancing from lab based R&D through research center based pilot and on to demonstration based operations building out a portfolio of biorefining IP, physical assets, and commercial opportunities. ZeaChem has 34 published patents around its core C2 & C3 bacterial fermentation technology. ZeaChem has built and operates a multi-million dollar, 10 bone dry ton per day input, 250,000 gal per year ethanol or equivalent biochemical output, demonstration plant in Boardman, OR. ZeaChem is actively engineering its 1st Commercial project, which will be located adjacent to the demonstration plant and is continuously developing a portfolio of projects that will follow behind Boardman throughout the United States and around the world. Each component of ZeaChem – Technologist, Technology Institute, Project Developer – compliments and drives the growth of the other. ZeaChem built the plant in Oregon to demonstrate its core technology platform at scale. ZeaChem opened the plant as a technology institute to third parties, which has created two profoundly beneficial outcomes. First, the third parties who come and work at the demo plant are able to dramatically accelerate the scale up of their own technology at a fraction of the cost to building and owning a plant of their own. Second, it has created foundational relationships for mutually beneficial project development activities at its 1st Commercial plant in Boardman and around the world.

An introduction to ZeaChem